SOFIA COSMETICA
ActiveSummary
SOFIA COSMETICA has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €577,957 and a net result of €4,074. Equity is growing by ~10.6% per year across the filed fiscal years. Its solvency ranks better than 64% of 50 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability38▼-14
Solvency80▲+5
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35,000 at 30 days acceptable
Liquidity ample (current ratio 2.38 against 2.13 in 2024; short-term debt: 38.5% and cash: 22.7% of total assets), and 45.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
54.7%
Return on assets
0.4%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 d early
2024
13 d early
2023
29 d late
2022
53 d late
2021
58 d late
2020
16 d late
2019
69 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 28 days after the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 August (4 of the last 5 filed years within 43 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#5 oldest company in Herk-de-Stad, Manufacturing sector
Equity
€577,957▲ 0.7%
2024 · €573,883
Total assets
€1.1m▼ 7.2%
2024 · €1.1m
Net result
€4,074▼ 83.8%
2024 · €25,111
Working capital
€559,783▲ 2.2%
2024 · €547,934
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€90,015▲ 4,513%€51,022▼ 43.3%€239,516▲ 369%€46,174▼ 80.7%€19,721▼ 57.3%
Net result€58,934within the sector's middle half€27,284within the sector's middle half▼ 53.7%€147,845within the sector's middle half▲ 442%€25,111within the sector's middle half▼ 83.0%€4,074within the sector's middle half▼ 83.8%
Equity€373,642within the sector's middle half▲ 18.7%€400,926within the sector's middle half▲ 7.3%€548,772within the sector's middle half▲ 36.9%€573,883within the sector's middle half▲ 4.6%€577,957within the sector's middle half▲ 0.7%
Total assets€960,415within the sector's middle half▲ 0.8%€1.1mwithin the sector's middle half▲ 15.4%€1.1mwithin the sector's middle half▲ 3.2%€1.1mwithin the sector's middle half▼ 0.4%€1.1mwithin the sector's middle half▼ 7.2%
Debt€555,481▼ 8.3%€677,260▲ 21.9%€594,241▼ 12.3%€565,095▼ 4.9%€479,381▼ 15.2%
Working capital€268,693within the sector's middle half▲ 27.0%€272,390within the sector's middle half▲ 1.4%€590,841within the sector's middle half▲ 117%€547,934above the sector's middle half▼ 7.3%€559,783above the sector's middle half▲ 2.2%
Solvency38.9%within the sector's middle half▲ 5.9pp36.2%within the sector's middle half▼ 2.7pp48.0%within the sector's middle half▲ 11.8pp50.4%within the sector's middle half▲ 2.4pp54.7%within the sector's middle half▲ 4.3pp
Current ratio1.81within the sector's middle half▲ 0.201.59within the sector's middle half▼ 0.222.22within the sector's middle half▲ 0.642.13within the sector's middle half▼ 0.092.38within the sector's middle half▲ 0.24
Return on assets (ROA)6.1%within the sector's middle half▲ 7.7pp2.5%within the sector's middle half▼ 3.7pp12.9%within the sector's middle half▲ 10.5pp2.2%within the sector's middle half▼ 10.7pp0.4%within the sector's middle half▼ 1.8pp
Staff (FTE)1.3▲ 30.0%1.5below the sector's middle half▲ 15.4%1.3within the sector's middle half▼ 13.3%2.6within the sector's middle half▲ 100%2.6=
above
within
below
the middle half (P25 to P75) of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 57% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets
€90,996 ▼ 15.2%
Current assets
€966,342 ▼ 6.3%
Equity and liabilities €1.1m
Equity
€577,957 ▲ 0.7%
Debt
€479,381 ▼ 15.2%
Debt's share of the balance-sheet total falls from 49.6% to 45.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€40,455▼
2024 · €64,020
Cash flow
€24,808▼
2024 · €42,958
Quick ratio
1.07▲
2024 · 0.96
Debt to equity
0.83▼
2024 · 0.98
ROE
0.7%▼
2024 · 4.4%
Interest coverage
2.30▼
2024 · 3.68
Debt ≤ 1 year
€406,558▼
2024 · €483,774
Debt > 1 year
€59,224▼
2024 · €78,917
Income taxes
€2,778▼
2024 · €11,823
Staff costs
€126,445▼
2024 · €126,914
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,039 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 94% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
0.5%
went bankrupt
4.9%
stopped otherwise
94%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,039 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €231,681 | €0 | - | - |
| Remuneration, social security and pensions62 | €67,837 | €58,274 | €46,740 | €126,914 | €126,445 | ▼ 0.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €32,189 | €38,474 | €13,443 | €17,846 | €20,734 | ▲ 16.2% |
| Other operating charges640/8 | €4,124 | €4,270 | €2,218 | €1,547 | €1,477 | ▼ 4.5% |
| Gross operating margin9900 | €194,166 | €152,041 | €301,917 | €192,482 | €168,377 | ▼ 12.5% |
| Operating profit (loss)9901 | €90,015 | €51,022 | €239,516 | €46,174 | €19,721 | ▼ 57.3% |
| Financial income75/76B | €3,898 | €4,001 | €15,560 | €8,166 | €4,721 | ▼ 42.2% |
| Recurring financial income75 | €3,898 | €4,001 | €15,560 | €8,166 | €4,721 | ▼ 42.2% |
| Financial charges65/66B | €20,041 | €20,689 | €22,581 | €17,406 | €17,590 | ▲ 1.1% |
| Recurring financial charges65 | €20,041 | €20,689 | €22,581 | €17,406 | €17,590 | ▲ 1.1% |
| Profit (loss) for the period before taxes9903 | €73,872 | €34,334 | €232,496 | €36,934 | €6,852 | ▼ 81.4% |
| Transfer from deferred taxes780 | €1,529 | €1,530 | €29,762 | €0 | - | - |
| Income taxes67/77 | €16,467 | €8,580 | €114,412 | €11,823 | €2,778 | ▼ 76.5% |
| Profit (loss) for the period9904 | €58,934 | €27,284 | €147,845 | €25,111 | €4,074 | ▼ 83.8% |
| Transfer from tax-exempt reserves789 | €4,586 | €4,590 | €89,286 | €0 | - | - |
| Profit (loss) for the period to be appropriated9905 | €63,520 | €31,874 | €237,131 | €25,111 | €4,074 | ▼ 83.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €960,415 | €1.1m | €1.1m | €1.1m | €1.1m | ▼ 7.2% |
| Fixed assets21/28 | €359,707 | €372,094 | €69,186 | €107,270 | €90,996 | ▼ 15.2% |
| Tangible fixed assets22/27 | €359,069 | €370,856 | €68,848 | €106,931 | €90,657 | ▼ 15.2% |
| Land and buildings22 | €335,534 | €323,979 | €0 | - | - | - |
| Plant, machinery and equipment23 | €21,281 | €46,876 | €37,701 | €100,780 | €85,531 | ▼ 15.1% |
| Furniture and vehicles24 | €2,253 | - | - | - | - | - |
| Other tangible fixed assets26 | - | - | €7,176 | €6,151 | €5,126 | ▼ 16.7% |
| Assets under construction and advance payments27 | - | - | €23,970 | €0 | - | - |
| Financial fixed assets28 | €638 | €1,238 | €338 | €338 | €338 | = |
| Current assets29/58 | €600,708 | €735,855 | €1.1m | €1.0m | €966,342 | ▼ 6.3% |
| Stocks and contracts in progress3 | €446,960 | €512,620 | €541,412 | €565,500 | €531,140 | ▼ 6.1% |
| Stocks30/36 | €446,960 | €512,620 | €541,412 | €565,500 | €531,140 | ▼ 6.1% |
| Amounts receivable within one year40/41 | €120,318 | €127,564 | €134,591 | €126,029 | €182,070 | ▲ 44.5% |
| Trade receivables40 | €107,218 | €105,891 | €124,741 | €72,039 | €61,451 | ▼ 14.7% |
| Other amounts receivable41 | €13,100 | €21,673 | €9,850 | €53,990 | €120,620 | ▲ 123% |
| Current investments50/53 | - | - | €250,000 | €200,000 | €0 | ▼ 100% |
| Cash at bank and in hand54/58 | €27,932 | €89,252 | €127,731 | €126,210 | €240,272 | ▲ 90.4% |
| Deferred charges and accrued income490/1 | €5,499 | €6,419 | €20,093 | €13,970 | €12,860 | ▼ 7.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €960,415 | €1.1m | €1.1m | €1.1m | €1.1m | ▼ 7.2% |
| Equity10/15 | €373,642 | €400,926 | €548,772 | €573,883 | €577,957 | ▲ 0.7% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €128,075 | €123,485 | €270,199 | €295,199 | €295,199 | = |
| Non-distributable reserves130/1 | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | - | - | - | - |
| Tax-exempt reserves132 | €94,278 | €89,689 | €403 | €403 | €403 | = |
| Distributable reserves133 | €31,936 | €31,936 | €269,796 | €294,796 | €294,796 | = |
| Profit (loss) carried forward14 | €226,968 | €258,842 | €259,973 | €260,084 | €264,158 | ▲ 1.6% |
| Provisions and deferred taxes16 | €31,292 | €29,762 | €0 | - | - | - |
| Deferred taxes168 | €31,292 | €29,762 | €0 | - | - | - |
| Amounts payable17/49 | €555,481 | €677,260 | €594,241 | €565,095 | €479,381 | ▼ 15.2% |
| Amounts payable after more than one year17 | €218,328 | €210,059 | €103,249 | €78,917 | €59,224 | ▼ 25.0% |
| Financial debts170/4 | €192,630 | €191,802 | €103,249 | €78,917 | €59,224 | ▼ 25.0% |
| Other amounts payable178/9 | €25,698 | €18,256 | - | - | - | - |
| Amounts payable within one year42/48 | €332,015 | €463,465 | €482,986 | €483,774 | €406,558 | ▼ 16.0% |
| Current portion of amounts payable after more than one year42 | €34,997 | €39,133 | €30,456 | €24,332 | €19,694 | ▼ 19.1% |
| Financial debts43 | €38,889 | €120,126 | €141,836 | €137,322 | €139,278 | ▲ 1.4% |
| Credit institutions430/8 | €38,889 | €120,126 | €141,836 | €137,322 | €139,278 | ▲ 1.4% |
| Trade debts44 | €54,279 | €85,664 | €33,140 | €49,390 | €28,708 | ▼ 41.9% |
| Suppliers440/4 | €54,279 | €85,664 | €33,140 | €49,390 | €28,708 | ▼ 41.9% |
| Taxes, remuneration and social security45 | €32,394 | €26,648 | €72,059 | €87,903 | €21,042 | ▼ 76.1% |
| Taxes450/3 | €17,807 | €16,364 | €65,175 | €67,108 | €2,663 | ▼ 96.0% |
| Remuneration and social security454/9 | €14,587 | €10,285 | €6,885 | €20,795 | €18,380 | ▼ 11.6% |
| Other amounts payable47/48 | €171,456 | €191,893 | €205,495 | €184,828 | €197,836 | ▲ 7.0% |
| Accrued charges and deferred income492/3 | €5,138 | €3,737 | €8,005 | €2,404 | €13,599 | ▲ 466% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €58,934 | €27,284 | €147,845 | €25,111 | €4,074 | ▼ 83.8% |
| + Depreciation and write-downs630 | €32,189 | €38,474 | €13,443 | €17,846 | €20,734 | ▲ 16.2% |
| Operating cash flow (approximation) | €91,123 | €65,759 | €161,289 | €42,958 | €24,808 | ▼ 42.3% |
| Investment in fixed assets (approximation) | - | -€50,861 | €289,465 | -€55,930 | -€4,460 | ▲ 92.0% |
| Change in cash | - | €61,320 | €38,480 | -€1,521 | €114,062 | ▲ 7,599% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
18-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
31-12
Financial
Highest result since 2018net €147,845 ▲442%
Operating result €239,516, net result €147,845, both a record.
31-12
Financial
Equity above €500,000Eq €548,772 ▲36.9%
3 profitable years in a row build equity to €548,772.
22-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 53 days late
2022
27-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 58 days late
2021
31-12
Financial
Back to profitnet €58,934
Net result €58,934 after 2 loss-making years.
16-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 16 days late
2020
31-12
Financial
Weakest financial yearnet -€15,170
Net result drops to -€15,170, the lowest in the series; recovery starts the following year.
08-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 69 days late
2019
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
18-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 49 days late
2017
21-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 52 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herk-de-Stad · 1 establishment unit since 1986
Ground area
1,128 m²
Building footprint
496 m²
Volume, LiDAR
3,510 m³
2 parcels, Flanders · tallest building 13.5 m, ±2 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 establishment unit
De Pierpontstraat 2, 3540 Herk-de-Stad
since 19862.029.013.732
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71024C0001/00S002 | Flanders | 964 m² | 1 · 213 m² | 9.9 m · 2 fl. |
| 71024A0769/00A000 | Flanders | 164 m² | 1 · 282 m² | 13.5 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2022 list no shareholders, and no other source names one.
Holdings 1
-
4.84%
According to the 2022 annual accounts of SOFIA COSMETICA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Food safety, FASFC
1 siteHerk-de-Stad2.029.013.732
Similar companies · same sector, comparable size
OLYS Pharma
BE 0754.895.372
La Hulpe · Eq €578,974
LABORATOIRES SOPRELI
BE 0417.104.255
Anderlecht · Eq €596,319
San'Up
BE 0693.818.729
Aywaille · Eq €608,894
Groovy.Bio
BE 0776.937.633
Antwerpen · Eq €544,484
Unda
BE 0403.987.182
Aywaille · Eq €486,787
Of 148 companies in sector 21201 we hold annual accounts for 118. 57 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded24-02-1986
Fiscal year end31-12
Trade name NL
SOFIA
Activities, NACEBEL 2025
20420Manufacture of chemicals and chemical products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
E-invoicing
Reachable via Peppol
Peppol ID
0208:0428575692
Also
9925:BE0428575692
Registered
01-01-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.